antibody engineering: how phage selection produced the world's biggest selling drug
Published 10 years ago • 10K plays • Length 34:21
Download video MP4
Download video MP3
Similar videos
-
29:16
antibody engineering: antibody libraries in yeast: evolving from an academic research tool
-
29:45
antibody engineering: target/epitope selection, humaneering® and in vivo biology
-
2:53
highlights from the antibody engineering & therapeutics event
-
4:08
antibody engineering 2013: bo yu, ph.d., larix bioscience llc
-
2:19
antibody engineering 2013: geoff yarranton, ph.d., kalobios pharmaceuticals, inc
-
4:44
phage therapy: how does it work?
-
11:46
you are immune against every disease
-
11:49
how do monoclonal antibodies work? rituximab, infliximab, adalimumab and others
-
48:03
antibody engineering: a systems approach to studying disease enabled by emerging technologies
-
53:40
antibody engineering: generation of biospecific antibodies via fab-arm exchange
-
47:32
antibody engineering: epitope-focused immunogen design
-
3:15
antibody engineering 2015 interview: erica ollmann saphire, the scripps research institute
-
23:00
john desjarlais: "optimization and application of fc-containing bispecific antibodies"
-
3:04
antibody engineering 2013: leroy hood, m.d., ph.d., president, institute for systems biology
-
35:34
antibody engineering: towards computer based design of smart protein therapeutics
-
33:47
antibody engineering: membrane switch technology
-
35:38
andrew bradbury: "at the crossroads: getting to reproducible research antibodies"
-
2:09
antibody engineering 2013: jane k. osbourn, ph.d., medimmune
-
4:18
antibody engineering 2014 interview: ira pastan, national cancer institute
-
1:51
antibody engineering 2013: david baker, ph.d., professor of biochemistry, university of washington
-
0:35
antibody engineering & therapeutics europe 2024
Clip.africa.com - Privacy-policy